Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology · Small Fiber Neuropathy

Is Small Fiber Neuropathy Genetic or Hereditary? Explained

At a Glance

Most small fiber neuropathy is acquired or has no identified cause, so it is not usually passed to children. Rare inherited forms involve specific gene variants; early onset, a family history, or related organ symptoms may prompt genetic counseling and testing.

SFN itself is a pattern of nerve injury; whether it can run in a family depends on the underlying cause. For the vast majority of people, small fiber neuropathy is acquired (caused by another condition) or idiopathic (cause unknown after evaluation), and is not directly passed to children [1]. However, a small percentage of cases are caused by rare, specific genetic variants [2]. If a pathogenic variant (a genetic change proven to cause disease) is identified, there is a risk of passing it on, but the exact chance depends on the specific gene involved [2]. Worrying about your children is completely understandable, but you should not assume you have passed anything on unless a specific hereditary cause is confirmed.

What This Means For Your Children

  • Acquired or Idiopathic SFN: If your SFN is caused by conditions like diabetes, autoimmune disease, or vitamin deficiencies, it is not a direct genetic disease passed to your children [3]. Even if the cause is idiopathic, the risk to children is generally low [4].
  • Autosomal Dominant Conditions: Many pathogenic variants in sodium-channel genes (like SCN9A) and genes associated with certain amyloidoses (like TTR) follow this pattern [2]. If a parent has one of these variants, there is a 50% chance of passing it to each child.
  • X-Linked Conditions: Conditions like Fabry disease are located on the X chromosome [5]. The risk of passing it on depends on whether the parent is male or female, and the sex of the child.
  • Autosomal Recessive Conditions: In rare associations like Pompe disease, a child must inherit a variant from both parents to develop the condition [6].

Note: Genetic disease can still occur even if you have no family history. This can be due to a new mutation in you (de novo variant), small family sizes, or “incomplete penetrance” (where family members carry the variant but never show symptoms).

The Genetic Link: Sodium Channel Variants

In recent years, researchers have found that pathogenic variants in certain genes—specifically SCN9A, SCN10A, and SCN11A—can cause hereditary SFN [2]. These genes control sodium channels, which act like microscopic gates that help your small nerve fibers send pain signals to your brain.

  • Gain-of-function variants: These make the sodium channels overly active, leading to severe, sometimes episodic, neuropathic pain and abnormal temperature sensation [7] [8].
  • Loss-of-function variants: These make the channels inactive. When this happens specifically in the SCN9A gene, it typically causes a separate condition called congenital insensitivity to pain (an inability to feel pain), rather than painful SFN [9].

Other Inherited Conditions

SFN or similar nerve pain can also be a symptom of broader, inherited systemic diseases:

  • Fabry disease: An X-linked disorder that can cause severe nerve pain in the hands and feet alongside autonomic issues (abnormal sweating or gastrointestinal problems) [5].
  • Hereditary transthyretin amyloidosis (hATTR): An autosomal dominant condition causing a progressive mixed-fiber polyneuropathy (affecting both large and small nerves) often accompanied by significant heart or autonomic problems [6].
  • Pompe disease: A rare inherited disorder that has been uncommonly associated with SFN [6].

Identifying these conditions is crucial because disease-specific treatments exist. However, it is important to know that these therapies generally aim to slow the progression of the disease or protect organs, rather than reversing existing nerve damage [6] [5].

When is Genetic Testing Recommended?

Genetic testing does not replace a standard evaluation for treatable acquired causes like abnormal glucose levels, vitamin deficiencies, alcohol or neurotoxic medication use, thyroid disease, or autoimmune conditions [10].

Because targeted testing has a very low yield in unselected, isolated idiopathic SFN, indiscriminate genetic testing is not recommended [11] [12]. A neurologist or neurogeneticist (a neurologist specializing in genetics) might consider testing if:

  • Your symptoms began at a young age: SFN starting in childhood, adolescence, or early adulthood [10].
  • You have a family history: Biological relatives have unexplained severe pain, reduced pain sensation, or neuropathy [13].
  • You have systemic symptoms: Clues like fainting, severe gastrointestinal issues, or heart/kidney disease alongside nerve pain [5].

Understanding Genetic Test Results

Broad genetic panels can sometimes produce a Variant of Uncertain Significance (VUS). A VUS means a genetic change was found, but there isn’t enough medical evidence to prove it causes disease. A VUS should generally not be used to guide testing for your family members. Additionally, a completely negative genetic panel does not definitively rule out every possible genetic cause.

Before and after testing, working with a genetic counselor is highly recommended to understand what a positive, negative, or VUS result means, and to navigate the potential emotional, privacy, and insurance implications for you and your family.

Plain-Language Glossary

  • Autonomic: Involuntary bodily functions like heart rate, digestion, and sweating.
  • Gain-of-function / Loss-of-function: A genetic variant that makes a gene’s product overly active (gain) or inactive (loss).
  • Idiopathic: A condition where no underlying cause has been identified despite thorough medical evaluation.
  • Neurogeneticist: A neurologist with specialized training in genetic conditions.
  • Pathogenic Variant: A specific genetic change that has been clinically proven to cause a disease.

Common questions in this guide

Is small fiber neuropathy usually inherited?
Usually not. Most small fiber neuropathy is acquired from another condition, such as diabetes, autoimmune disease, vitamin deficiency, alcohol or neurotoxic medication exposure, or it is idiopathic, meaning no cause is found. Only a small proportion is caused by a specific inherited genetic variant.
Can I pass small fiber neuropathy to my children?
If your neuropathy is acquired or idiopathic, it is generally not directly passed to your children. If testing identifies a pathogenic variant, the chance depends on the gene and inheritance pattern; some autosomal dominant conditions carry a 50% chance for each child, while X-linked and recessive conditions follow different rules. A genetic counselor can calculate the risk for your family.
When should someone with small fiber neuropathy consider genetic testing?
Genetic testing may be considered when symptoms begin in childhood, adolescence, or early adulthood; when relatives have unexplained neuropathy or severe pain; or when nerve symptoms occur with problems such as abnormal sweating, digestive symptoms, fainting, or heart or kidney disease. Doctors generally evaluate treatable acquired causes first because testing has a low yield in isolated idiopathic SFN.
Which inherited conditions or genes can cause small fiber neuropathy?
Pathogenic variants in SCN9A, SCN10A, and SCN11A can cause hereditary small fiber neuropathy by altering sodium channels in small nerve fibers. Small-fiber or mixed-fiber nerve problems can also occur with inherited conditions such as Fabry disease, hereditary transthyretin amyloidosis, and, less commonly, Pompe disease.
Can a genetic cause exist if no one else in my family has neuropathy?
Yes. A new genetic change can arise in a person without being inherited from a parent. A small family size or incomplete penetrance, in which some people carry a variant without symptoms, can also hide a family pattern.
What does a VUS or negative genetic test mean for small fiber neuropathy?
A variant of uncertain significance, or VUS, is a genetic change that has not been shown to cause disease, so it usually should not guide testing of relatives. A negative panel lowers the chance of the variants it tested for but does not rule out every genetic cause. A genetic counselor can explain how either result affects care and family decisions.
Can treatment help if genetic testing finds a cause?
Identifying an inherited condition can open access to disease-specific treatments. These therapies generally aim to slow disease progression or protect organs rather than reverse nerve damage that has already occurred. Treatment depends on the condition and should be discussed with a specialist.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my age of onset and symptoms, is a referral for genetic counseling or testing appropriate?
  2. 2.What specific acquired causes (like diabetes, vitamin levels, or autoimmune issues) have we already thoroughly ruled out?
  3. 3.If a pathogenic variant is found, what is the exact inheritance chance for my children?
  4. 4.What would a variant of uncertain significance (VUS) or a negative result mean for my care?
  5. 5.If we identify a genetic cause, are there treatments available to slow its progression?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Associated conditions in small fiber neuropathy - a large cohort study and review of the literature.

    de Greef BTA, Hoeijmakers JGJ, Gorissen-Brouwers CML, et al.

    European journal of neurology 2018; (25(2)):348-355 doi:10.1111/ene.13508.

    PMID: 29112785
  2. 2

    Expanding the genetic causes of small-fiber neuropathy: SCN genes and beyond.

    Chan ACY, Kumar S, Tan G, et al.

    Muscle & nerve 2023; (67(4)):259-271 doi:10.1002/mus.27752.

    PMID: 36448457
  3. 3

    Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability.

    Johnson SA, Shouman K, Shelly S, et al.

    Neurology 2021; (97(22)):e2236-e2247 doi:10.1212/WNL.0000000000012894.

    PMID: 34706972
  4. 4

    Small fiber neuropathy: Swiss cohort characterization.

    Bitzi LM, Lehnick D, Wilder-Smith EP

    Muscle & nerve 2021; (64(3)):293-300 doi:10.1002/mus.27340.

    PMID: 34075618
  5. 5

    Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease.

    Finsterer J, Wanschitz J, Quasthoff S, et al.

    Acta neurologica Scandinavica 2017; (136(6)):558-569 doi:10.1111/ane.12758.

    PMID: 28295152
  6. 6

    [Neuropathic pain as a symptom in autonomic neuropathies and other rare diseases : Small fiber neuropathy: its recognition, diagnosis, and treatment].

    Fischer F, Dohrn MF, Kapfenberger R, et al.

    Schmerz (Berlin, Germany) 2024; (38(1)):33-40 doi:10.1007/s00482-023-00783-w.

    PMID: 38197939
  7. 7

    The Human SCN9A Point Mutation Induces Pain Hypersensitivity and Spontaneous Pain in Mice.

    Xue Y, Kremer M, Muniz Moreno MDM, et al.

    Frontiers in molecular neuroscience 2022; (15()):913990 doi:10.3389/fnmol.2022.913990.

    PMID: 35769334
  8. 8

    Infantile Pain Episodes Associated with Novel Nav1.9 Mutations in Familial Episodic Pain Syndrome in Japanese Families.

    Okuda H, Noguchi A, Kobayashi H, et al.

    PloS one 2016; (11(5)):e0154827 doi:10.1371/journal.pone.0154827.

    PMID: 27224030
  9. 9

    Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7.

    Minett MS, Pereira V, Sikandar S, et al.

    Nature communications 2015; (6()):8967 doi:10.1038/ncomms9967.

    PMID: 26634308
  10. 10

    Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review.

    Oaklander AL, Nolano M

    JAMA neurology 2019; (76(10)):1240-1251 doi:10.1001/jamaneurol.2019.2917.

    PMID: 31498378
  11. 11

    Screening for Fabry disease and Hereditary ATTR amyloidosis in idiopathic small-fiber and mixed neuropathy.

    Samuelsson K, Radovic A, Press R, et al.

    Muscle & nerve 2019; (59(3)):354-357 doi:10.1002/mus.26348.

    PMID: 30246259
  12. 12

    No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy.

    de Greef BT, Hoeijmakers JG, Wolters EE, et al.

    PloS one 2016; (11(2)):e0148316 doi:10.1371/journal.pone.0148316.

    PMID: 26866599
  13. 13

    Hereditary transthyretin-related amyloidosis.

    Finsterer J, Iglseder S, Wanschitz J, et al.

    Acta neurologica Scandinavica 2019; (139(2)):92-105 doi:10.1111/ane.13035.

    PMID: 30295933

This page explains the possible hereditary causes of small fiber neuropathy for informational purposes only and does not constitute medical advice. A neurologist, genetic counselor, or neurogeneticist can help interpret your personal and family risk.

Get notified when new evidence is published on neuropathy, small fiber.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.